Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid
Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid
Lucira Health Inc (OTC:LHDXQ) has been acquired by Pfizer Inc (NYSE:PFE) for $36.4 million through a bankruptcy auction. According to the SEC document, the asset sale closed on April 20.
露西拉健康公司 （OTC: LHDXQ）已被收購 輝瑞公司 紐約證券交易所代碼：PFE）通過破產拍賣以3640萬美元的價格出售。根據 秒 文件，資產出售於4月20日結束。
The company filed for bankruptcy in February, just two days before receiving FDA Emergency Use Authorization for the first over-the-counter (OTC) at-home diagnostic test to differentiate and detect influenza A and B.
該公司在二月份申請破產，就在獲得美國食品藥品管理局緊急使用授權的前兩天，首次用於區分和檢測甲型和乙型流感的非處方（OTC）家庭診斷測試
COVID-19 & Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes.
COVID-19 & Flu Home Test 是一款一次性家用測試套件，可在大約 30 分鐘內提供自採鼻拭子樣本的結果。
In the SEC filing, it said Pfizer entered the winning bid in an April 6 auction for Lucira's assets.
在美國證券交易委員會的文件中，該公司表示，輝瑞在4月6日對盧西拉資產的拍賣中中標。
Lucira Health snowballed over the past several years amid the COVID-19 pandemic. Demand for the company's COVID-19 test kits surged, and it posted positive net income in its 2022 first quarter for the first time since its inception.
在過去的幾年中，在 COVID-19 疫情期間，Lucira Health 的規模激增。對該公司 COVID-19 測試套件的需求激增，該公司自成立以來首次在 2022 年第一季度公佈正淨收入。
Also Read: FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report.
另請閱讀：《華爾街日報》報道，美國食品藥品管理局的監管延遲是Novavax、Lucira Health失敗的原因。
During filing for Chapter 11, the company said a protracted EUA process for its COVID-19 and influenza test had been costly without new revenue from the combined test kit during the 2022-2023 flu season.
在申請第 11 章時，該公司表示，在 2022-2023 年流感季節，如果聯合檢測試劑盒沒有新的收入，EUA 的 COVID-19 和流感測試過程曠日持久，成本高昂。
FDA officials responded to the statements about a perceived lengthy EUA process, saying it had found Lucira's COVID-19 and flu test had contained a toxic substance in one of the test components.
美國食品藥品管理局官員對有關歐盟程序可能漫長的聲明做出了回應，稱發現盧西拉的 COVID-19 和流感測試在其中一個測試成分中含有有毒物質。
Price Action: PFE shares are up 0.18% at $38.81 on the last check Friday.
價格走勢： 在週五的最後一張支票中，PFE股價上漲了0.18％，至38.81美元。